FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1
The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of...
Gespeichert in:
| Veröffentlicht in: | Cancer science 2018-12, Vol.109 (12), p.3883-3895 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3895 |
|---|---|
| container_issue | 12 |
| container_start_page | 3883 |
| container_title | Cancer science |
| container_volume | 109 |
| creator | Mori, Akiko Masuda, Kunihiro Ohtsuka, Hideo Shijo, Masahiro Ariake, Kyohei Fukase, Koji Sakata, Naoaki Mizuma, Masamichi Morikawa, Takanori Hayashi, Hiroki Nakagawa, Kei Motoi, Fuyuhiko Naitoh, Takeshi Fujishima, Fumiyoshi Unno, Michiaki |
| description | The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of FBXW7 in cholangiocarcinoma. We found that FBXW7 expression was associated with clinicopathological outcomes in cholangiocarcinoma patients. Both disease‐free and overall survival were significantly worse in the low‐FBXW7 group than in the high‐FBXW7 group (P = .001 and P |
| doi_str_mv | 10.1111/cas.13829 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6272118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2117821317</sourcerecordid><originalsourceid>FETCH-LOGICAL-j3969-e7cb8f9f5ed3e343de85dda7bd16d01acceeb88f92cd9759ceef4e937a56a2553</originalsourceid><addsrcrecordid>eNpVkc9OwzAMxiME4v-BF0A5cilLmrZpLkgwMUAacAAEt8hLsi2oTUrTgrjxCDwjT0IYA4EvtuWfPsv-ENqj5JDGGCgIh5SVqVhBm5RlIuGEFKuLmieCsHQDbYXwSAgrMpGtow1GGEnLgm-iMDp5uOe49rqvoDMB11DZmQPX4cZ3xnUWKgxOY2VDEwnrPt7erdO9MhpD45vOBxuwdVjNfQVuZr2CVlnna8DdvPX9bI6vrm-H53Qhczkc0x20NoUqmN1l3kZ3o9NIJOPrs4vh8Th5ZKIQieFqUk7FNDeaGZYxbcpca-ATTQtNKChlzKSMRKq04LmI7TQzgnHIC0jznG2jo2_dpp_URqt4TQuVbFpbQ_sqPVj5f-LsXM78syxSnlJaRoGDpUDrn3oTOlnboEwV7zS-DzJCvEwpozyi-393_S75-XQEBt_Ai63M6--cEvlloYwWyoWFcnh8syjYJ13Mklc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117821317</pqid></control><display><type>article</type><title>FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>PubMed Central</source><creator>Mori, Akiko ; Masuda, Kunihiro ; Ohtsuka, Hideo ; Shijo, Masahiro ; Ariake, Kyohei ; Fukase, Koji ; Sakata, Naoaki ; Mizuma, Masamichi ; Morikawa, Takanori ; Hayashi, Hiroki ; Nakagawa, Kei ; Motoi, Fuyuhiko ; Naitoh, Takeshi ; Fujishima, Fumiyoshi ; Unno, Michiaki</creator><creatorcontrib>Mori, Akiko ; Masuda, Kunihiro ; Ohtsuka, Hideo ; Shijo, Masahiro ; Ariake, Kyohei ; Fukase, Koji ; Sakata, Naoaki ; Mizuma, Masamichi ; Morikawa, Takanori ; Hayashi, Hiroki ; Nakagawa, Kei ; Motoi, Fuyuhiko ; Naitoh, Takeshi ; Fujishima, Fumiyoshi ; Unno, Michiaki</creatorcontrib><description>The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of FBXW7 in cholangiocarcinoma. We found that FBXW7 expression was associated with clinicopathological outcomes in cholangiocarcinoma patients. Both disease‐free and overall survival were significantly worse in the low‐FBXW7 group than in the high‐FBXW7 group (P = .001 and P < .001, respectively). Multivariate analysis with the Cox proportional hazards model indicated that FBXW7 was the most important independent prognostic factor for disease‐free (P = .006) and overall (P = .0004) survival. We also showed that the two FBXW7 substrates, NOTCH1 and myeloid cell leukemia sequence 1 (MCL1), regulate cholangiocarcinoma progression. Depletion of FBXW7 resulted in NOTCH1 accumulation and increased cholangiocarcinoma cell migration and self‐renewal. Interestingly, when cells were stimulated with cis‐diamminedichloridoplatinum(II) (cisplatin), FBXW7 suppression induced MCL1 upregulation, which reduced the sensitivity of cholangiocarcinoma cells to apoptosis, indicating that FBXW7‐mediated ubiquitylation is context‐dependent. These results indicate that FBXW7 modulates the malignant potential of cholangiocarcinoma through independent regulation of NOTCH1 and MCL1.
The ubiquitin ligase FBXW7 is associated with prognostic outcome in cholangiocarcinoma patients. FBXW7 was found to regulate the migration and self‐renewal of cholangiocarcinoma cells through modulation of NOTCH1 as well as CDDP‐induced apoptosis through MCL1 accumulation for the first time in cholangiocarcinoma cells. These findings suggest that FBXW7 modulates the malignant potential of cholangiocarcinoma through two signals, NOTCH1 and MCL1.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.13829</identifier><identifier>PMID: 30302867</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bile Duct Neoplasms - metabolism ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; cholangiocarcinoma ; Cholangiocarcinoma - metabolism ; cisplatin ; Cisplatin - pharmacology ; Disease Progression ; Down-Regulation ; F-Box-WD Repeat-Containing Protein 7 - metabolism ; FBXW7 protein ; Gene Expression Regulation, Neoplastic ; Humans ; Middle Aged ; myeloid cell leukemia sequence 1 protein ; Myeloid Cell Leukemia Sequence 1 Protein - metabolism ; NOTCH1 protein ; Original ; Prognosis ; Receptor, Notch1 - metabolism ; Survival Analysis</subject><ispartof>Cancer science, 2018-12, Vol.109 (12), p.3883-3895</ispartof><rights>2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-6879-5899</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272118/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272118/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30302867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mori, Akiko</creatorcontrib><creatorcontrib>Masuda, Kunihiro</creatorcontrib><creatorcontrib>Ohtsuka, Hideo</creatorcontrib><creatorcontrib>Shijo, Masahiro</creatorcontrib><creatorcontrib>Ariake, Kyohei</creatorcontrib><creatorcontrib>Fukase, Koji</creatorcontrib><creatorcontrib>Sakata, Naoaki</creatorcontrib><creatorcontrib>Mizuma, Masamichi</creatorcontrib><creatorcontrib>Morikawa, Takanori</creatorcontrib><creatorcontrib>Hayashi, Hiroki</creatorcontrib><creatorcontrib>Nakagawa, Kei</creatorcontrib><creatorcontrib>Motoi, Fuyuhiko</creatorcontrib><creatorcontrib>Naitoh, Takeshi</creatorcontrib><creatorcontrib>Fujishima, Fumiyoshi</creatorcontrib><creatorcontrib>Unno, Michiaki</creatorcontrib><title>FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of FBXW7 in cholangiocarcinoma. We found that FBXW7 expression was associated with clinicopathological outcomes in cholangiocarcinoma patients. Both disease‐free and overall survival were significantly worse in the low‐FBXW7 group than in the high‐FBXW7 group (P = .001 and P < .001, respectively). Multivariate analysis with the Cox proportional hazards model indicated that FBXW7 was the most important independent prognostic factor for disease‐free (P = .006) and overall (P = .0004) survival. We also showed that the two FBXW7 substrates, NOTCH1 and myeloid cell leukemia sequence 1 (MCL1), regulate cholangiocarcinoma progression. Depletion of FBXW7 resulted in NOTCH1 accumulation and increased cholangiocarcinoma cell migration and self‐renewal. Interestingly, when cells were stimulated with cis‐diamminedichloridoplatinum(II) (cisplatin), FBXW7 suppression induced MCL1 upregulation, which reduced the sensitivity of cholangiocarcinoma cells to apoptosis, indicating that FBXW7‐mediated ubiquitylation is context‐dependent. These results indicate that FBXW7 modulates the malignant potential of cholangiocarcinoma through independent regulation of NOTCH1 and MCL1.
The ubiquitin ligase FBXW7 is associated with prognostic outcome in cholangiocarcinoma patients. FBXW7 was found to regulate the migration and self‐renewal of cholangiocarcinoma cells through modulation of NOTCH1 as well as CDDP‐induced apoptosis through MCL1 accumulation for the first time in cholangiocarcinoma cells. These findings suggest that FBXW7 modulates the malignant potential of cholangiocarcinoma through two signals, NOTCH1 and MCL1.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bile Duct Neoplasms - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>cholangiocarcinoma</subject><subject>Cholangiocarcinoma - metabolism</subject><subject>cisplatin</subject><subject>Cisplatin - pharmacology</subject><subject>Disease Progression</subject><subject>Down-Regulation</subject><subject>F-Box-WD Repeat-Containing Protein 7 - metabolism</subject><subject>FBXW7 protein</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>myeloid cell leukemia sequence 1 protein</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</subject><subject>NOTCH1 protein</subject><subject>Original</subject><subject>Prognosis</subject><subject>Receptor, Notch1 - metabolism</subject><subject>Survival Analysis</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNpVkc9OwzAMxiME4v-BF0A5cilLmrZpLkgwMUAacAAEt8hLsi2oTUrTgrjxCDwjT0IYA4EvtuWfPsv-ENqj5JDGGCgIh5SVqVhBm5RlIuGEFKuLmieCsHQDbYXwSAgrMpGtow1GGEnLgm-iMDp5uOe49rqvoDMB11DZmQPX4cZ3xnUWKgxOY2VDEwnrPt7erdO9MhpD45vOBxuwdVjNfQVuZr2CVlnna8DdvPX9bI6vrm-H53Qhczkc0x20NoUqmN1l3kZ3o9NIJOPrs4vh8Th5ZKIQieFqUk7FNDeaGZYxbcpca-ATTQtNKChlzKSMRKq04LmI7TQzgnHIC0jznG2jo2_dpp_URqt4TQuVbFpbQ_sqPVj5f-LsXM78syxSnlJaRoGDpUDrn3oTOlnboEwV7zS-DzJCvEwpozyi-393_S75-XQEBt_Ai63M6--cEvlloYwWyoWFcnh8syjYJ13Mklc</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Mori, Akiko</creator><creator>Masuda, Kunihiro</creator><creator>Ohtsuka, Hideo</creator><creator>Shijo, Masahiro</creator><creator>Ariake, Kyohei</creator><creator>Fukase, Koji</creator><creator>Sakata, Naoaki</creator><creator>Mizuma, Masamichi</creator><creator>Morikawa, Takanori</creator><creator>Hayashi, Hiroki</creator><creator>Nakagawa, Kei</creator><creator>Motoi, Fuyuhiko</creator><creator>Naitoh, Takeshi</creator><creator>Fujishima, Fumiyoshi</creator><creator>Unno, Michiaki</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6879-5899</orcidid></search><sort><creationdate>201812</creationdate><title>FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1</title><author>Mori, Akiko ; Masuda, Kunihiro ; Ohtsuka, Hideo ; Shijo, Masahiro ; Ariake, Kyohei ; Fukase, Koji ; Sakata, Naoaki ; Mizuma, Masamichi ; Morikawa, Takanori ; Hayashi, Hiroki ; Nakagawa, Kei ; Motoi, Fuyuhiko ; Naitoh, Takeshi ; Fujishima, Fumiyoshi ; Unno, Michiaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j3969-e7cb8f9f5ed3e343de85dda7bd16d01acceeb88f92cd9759ceef4e937a56a2553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bile Duct Neoplasms - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>cholangiocarcinoma</topic><topic>Cholangiocarcinoma - metabolism</topic><topic>cisplatin</topic><topic>Cisplatin - pharmacology</topic><topic>Disease Progression</topic><topic>Down-Regulation</topic><topic>F-Box-WD Repeat-Containing Protein 7 - metabolism</topic><topic>FBXW7 protein</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>myeloid cell leukemia sequence 1 protein</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</topic><topic>NOTCH1 protein</topic><topic>Original</topic><topic>Prognosis</topic><topic>Receptor, Notch1 - metabolism</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mori, Akiko</creatorcontrib><creatorcontrib>Masuda, Kunihiro</creatorcontrib><creatorcontrib>Ohtsuka, Hideo</creatorcontrib><creatorcontrib>Shijo, Masahiro</creatorcontrib><creatorcontrib>Ariake, Kyohei</creatorcontrib><creatorcontrib>Fukase, Koji</creatorcontrib><creatorcontrib>Sakata, Naoaki</creatorcontrib><creatorcontrib>Mizuma, Masamichi</creatorcontrib><creatorcontrib>Morikawa, Takanori</creatorcontrib><creatorcontrib>Hayashi, Hiroki</creatorcontrib><creatorcontrib>Nakagawa, Kei</creatorcontrib><creatorcontrib>Motoi, Fuyuhiko</creatorcontrib><creatorcontrib>Naitoh, Takeshi</creatorcontrib><creatorcontrib>Fujishima, Fumiyoshi</creatorcontrib><creatorcontrib>Unno, Michiaki</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mori, Akiko</au><au>Masuda, Kunihiro</au><au>Ohtsuka, Hideo</au><au>Shijo, Masahiro</au><au>Ariake, Kyohei</au><au>Fukase, Koji</au><au>Sakata, Naoaki</au><au>Mizuma, Masamichi</au><au>Morikawa, Takanori</au><au>Hayashi, Hiroki</au><au>Nakagawa, Kei</au><au>Motoi, Fuyuhiko</au><au>Naitoh, Takeshi</au><au>Fujishima, Fumiyoshi</au><au>Unno, Michiaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2018-12</date><risdate>2018</risdate><volume>109</volume><issue>12</issue><spage>3883</spage><epage>3895</epage><pages>3883-3895</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of FBXW7 in cholangiocarcinoma. We found that FBXW7 expression was associated with clinicopathological outcomes in cholangiocarcinoma patients. Both disease‐free and overall survival were significantly worse in the low‐FBXW7 group than in the high‐FBXW7 group (P = .001 and P < .001, respectively). Multivariate analysis with the Cox proportional hazards model indicated that FBXW7 was the most important independent prognostic factor for disease‐free (P = .006) and overall (P = .0004) survival. We also showed that the two FBXW7 substrates, NOTCH1 and myeloid cell leukemia sequence 1 (MCL1), regulate cholangiocarcinoma progression. Depletion of FBXW7 resulted in NOTCH1 accumulation and increased cholangiocarcinoma cell migration and self‐renewal. Interestingly, when cells were stimulated with cis‐diamminedichloridoplatinum(II) (cisplatin), FBXW7 suppression induced MCL1 upregulation, which reduced the sensitivity of cholangiocarcinoma cells to apoptosis, indicating that FBXW7‐mediated ubiquitylation is context‐dependent. These results indicate that FBXW7 modulates the malignant potential of cholangiocarcinoma through independent regulation of NOTCH1 and MCL1.
The ubiquitin ligase FBXW7 is associated with prognostic outcome in cholangiocarcinoma patients. FBXW7 was found to regulate the migration and self‐renewal of cholangiocarcinoma cells through modulation of NOTCH1 as well as CDDP‐induced apoptosis through MCL1 accumulation for the first time in cholangiocarcinoma cells. These findings suggest that FBXW7 modulates the malignant potential of cholangiocarcinoma through two signals, NOTCH1 and MCL1.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>30302867</pmid><doi>10.1111/cas.13829</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-6879-5899</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1347-9032 |
| ispartof | Cancer science, 2018-12, Vol.109 (12), p.3883-3895 |
| issn | 1347-9032 1349-7006 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6272118 |
| source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; PubMed Central |
| subjects | Adult Aged Aged, 80 and over Bile Duct Neoplasms - metabolism Cell Line, Tumor Cell Proliferation - drug effects Cell Survival - drug effects cholangiocarcinoma Cholangiocarcinoma - metabolism cisplatin Cisplatin - pharmacology Disease Progression Down-Regulation F-Box-WD Repeat-Containing Protein 7 - metabolism FBXW7 protein Gene Expression Regulation, Neoplastic Humans Middle Aged myeloid cell leukemia sequence 1 protein Myeloid Cell Leukemia Sequence 1 Protein - metabolism NOTCH1 protein Original Prognosis Receptor, Notch1 - metabolism Survival Analysis |
| title | FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T05%3A48%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FBXW7%20modulates%20malignant%20potential%20and%20cisplatin%E2%80%90induced%20apoptosis%20in%20cholangiocarcinoma%20through%20NOTCH1%20and%20MCL1&rft.jtitle=Cancer%20science&rft.au=Mori,%20Akiko&rft.date=2018-12&rft.volume=109&rft.issue=12&rft.spage=3883&rft.epage=3895&rft.pages=3883-3895&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.13829&rft_dat=%3Cproquest_pubme%3E2117821317%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2117821317&rft_id=info:pmid/30302867&rfr_iscdi=true |